爱博医疗拟6.83亿元收购德美医疗68.31%股权

Core Viewpoint - Aibo Medical plans to acquire 68.31% equity of Demei United (Chongqing) Medical Technology Co., Ltd. for a total consideration of 683 million yuan, utilizing acquisition loans and its own funds [1] Group 1: Acquisition Details - The acquisition price for Demei Medical is set at 683 million yuan [1] - Aibo Medical aims to enhance its presence in the healthcare sector through this acquisition, focusing on collaboration in R&D, manufacturing, and sales channels [1] Group 2: Demei Medical Overview - Demei Medical has established itself as an international medical enterprise specializing in sports medicine, including the development, production, sales, and service of sports medicine implants, surgical tools, and rehabilitation equipment [1] - The core products of Demei Medical include full suture anchors, interface screws, ultra-strong sutures, reaming heads, arthroscopic cannulas, 4K ultra-precision camera systems, and adjustable braces, with sports medicine implants accounting for approximately 80% of its revenue [1] Group 3: Strategic Intent - Aibo Medical's core business focuses on the R&D and commercialization of biomedical materials and high-end medical devices [1] - The acquisition is expected to further improve Aibo Medical's performance and shareholder returns by leveraging synergies with Demei Medical [1]